Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease

NCT01562041 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT01562041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01562041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
March 9, 2012
Completion date
January 2, 2014
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic coronary vascular disease